Sigma-1 Receptors Regulate Bcl-2 Expression by Reactive Oxygen Species-Dependent Transcriptional Regulation of Nuclear Factor κB

The expression of Bcl-2, the major antiapoptotic member of the Bcl-2 family, is under complex controls of several factors, including reactive oxygen species (ROS). The σ-1 receptor (Sig-1R), which was recently identified as a novel molecular chaperone at the mitochondria-associated endoplasmic reticulum membrane (MAM), has been shown to exert robust cellular protective actions. However, mechanisms underlying the antiapoptotic action of the Sig-1R remain to be clarified. Here, we found that the Sig-1R promotes cellular survival by regulating the Bcl-2 expression in Chinese hamster ovary cells. Although both Sig-1Rs and Bcl-2 are highly enriched at the MAM, Sig-1Rs neither associate physically with Bcl-2 nor regulate stability of Bcl-2 proteins. However, Sig-1Rs tonically regulate the expression of Bcl-2 proteins. Knockdown of Sig-1Rs down-regulates whereas overexpression of Sig-1Rs up-regulates bcl-2 mRNA, indicating that the Sig-1R transcriptionally regulates the expression of Bcl-2. The effect of Sig-1R small interfering RNA down-regulating Bcl-2 was blocked by ROS scavengers and by the inhibitor of the ROS-inducible transcription factor nuclear factor κB (NF-κB). Knockdown of Sig-1Rs up-regulates p105, the precursor of NF-κB, while concomitantly decreasing inhibitor of nuclear factor-κBα. Sig-1R knockdown also accelerates the conversion of p105 to the active form p50. Lastly, we showed that knockdown of Sig-1Rs potentiates H2O2-induced apoptosis; the action is blocked by either the NF-κB inhibitor oridonin or overexpression of Bcl-2. Thus, these findings suggest that Sig-1Rs promote cell survival, at least in part, by transcriptionally regulating Bcl-2 expression via the ROS/NF-κB pathway.

[1]  S. Korsmeyer,et al.  Cell Death Critical Control Points , 2004, Cell.

[2]  L. Boxer,et al.  Oxidative stress‐mediated down‐regulation of bcl‐2 promoter in hippocampal neurons , 2003, Journal of neurochemistry.

[3]  A. Coop,et al.  Effects of UMB24 and (±)-SM 21, putative σ 2-preferring antagonists, on behavioral toxic and stimulant effects of cocaine in mice , 2007, Pharmacology Biochemistry and Behavior.

[4]  E. Castanas,et al.  Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[5]  T. Heinemeyer,et al.  Databases on transcriptional regulation : TRANSFAC , TRRD and COMPEL , 1997 .

[6]  Yang Yang,et al.  Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-κB signal pathways , 2005, Molecular Cancer Therapeutics.

[7]  Teruo Hayashi,et al.  Sigma-1 receptors (sigma(1) binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export. , 2003, The Journal of pharmacology and experimental therapeutics.

[8]  M. Jackson,et al.  The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator , 2009, Science.

[9]  V. Ganapathy,et al.  In vivo protection against retinal neurodegeneration by sigma receptor 1 ligand (+)-pentazocine. , 2008, Investigative ophthalmology & visual science.

[10]  E. Kempner,et al.  Purification, molecular cloning, and expression of the mammalian sigma1-binding site. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Sufang Yang,et al.  Sigma Receptor Agonists Provide Neuroprotection In Vitro by Preserving bcl-2 , 2007, Anesthesia and analgesia.

[12]  John Calvin Reed.  Bcl-2 and the regulation of programmed cell death , 1994, The Journal of cell biology.

[13]  T. Osaki,et al.  Reactive oxygen species (ROS) control the expression of Bcl‐2 family proteins by regulating their phosphorylation and ubiquitination , 2004, Cancer science.

[14]  L. Boxer,et al.  NF-κB activates Bcl-2 expression in t(14;18) lymphoma cells , 2002, Oncogene.

[15]  J. Simpkins,et al.  A prototypical Sigma-1 receptor antagonist protects against brain ischemia , 2007, Brain Research.

[16]  Yueh-Ching Chou,et al.  Anti‐inflammatory effects of dimemorfan on inflammatory cells and LPS‐induced endotoxin shock in mice , 2008, British journal of pharmacology.

[17]  L. Boxer,et al.  NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells. , 2002, Oncogene.

[18]  G. Dubyak,et al.  Evidence that BCL-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2+ fluxes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  T. Su,et al.  Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity , 2005, Neuroreport.

[20]  Teruo Hayashi,et al.  Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival , 2007, Cell.

[21]  T. Maurice,et al.  Neuroprotective and anti-amnesic potentials of sigma (σ) receptor ligands , 1997, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[22]  J. Vance,et al.  A unique mitochondria-associated membrane fraction from rat liver has a high capacity for lipid synthesis and contains pre-Golgi secretory proteins including nascent lipoproteins. , 1994, The Journal of biological chemistry.

[23]  D. Andrews,et al.  During apoptosis bcl-2 changes membrane topology at both the endoplasmic reticulum and mitochondria. , 2004, Molecular cell.

[24]  W. Bowen.  Sigma receptors: recent advances and new clinical potentials. , 2000, Pharmaceutica acta Helvetiae.

[25]  T. Maurice,et al.  Neuroprotective and anti-amnesic potentials of sigma (sigma) receptor ligands. , 1997, Progress in neuro-psychopharmacology & biological psychiatry.

[26]  E. Aydar,et al.  Sigma-1 receptors bind cholesterol and remodel lipid rafts in breast cancer cell lines. , 2007, Cancer research.

[27]  D. Voelker.  Bridging gaps in phospholipid transport. , 2005, Trends in biochemical sciences.

[28]  Ch'en Cl,et al.  Rel/NF-kappaB represses bcl-2 transcription in pro-B lymphocytes. , 1999 .

[29]  S. Korsmeyer,et al.  Alternative promoters and exons, somatic mutation and deregulation of the Bcl‐2‐Ig fusion gene in lymphoma. , 1988, The EMBO journal.

[30]  Teruo Hayashi,et al.  Sigma-1 receptors at galactosylceramide-enriched lipid microdomains regulate oligodendrocyte differentiation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[31]  A. Strasser,et al.  The BCL-2 protein family: opposing activities that mediate cell death , 2008, Nature Reviews Molecular Cell Biology.

[32]  M. Karin.  Nuclear factor-κB in cancer development and progression , 2006, Nature.

[33]  S. Snyder,et al.  Receptor mechanisms in antipsychotic drug action: focus on sigma receptors. , 1989, The Journal of neuropsychiatry and clinical neurosciences.

[34]  Teruo Hayashi,et al.  σ-1 Receptors (σ1 Binding Sites) Form Raft-Like Microdomains and Target Lipid Droplets on the Endoplasmic Reticulum: Roles in Endoplasmic Reticulum Lipid Compartmentalization and Export , 2003, Journal of Pharmacology and Experimental Therapeutics.

[35]  J. Ieni,et al.  The anti‐amnesic and neuroprotective effects of donepezil against amyloid β25‐35 peptide‐induced toxicity in mice involve an interaction with the σ1 receptor , 2006, British journal of pharmacology.

[36]  B. Aronow,et al.  Control of Bcl-2 expression by reactive oxygen species , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Korsmeyer,et al.  Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.

[38]  John Calvin Reed,et al.  Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. , 1993, Cancer research.

[39]  G. Hajnóczky,et al.  MAM: more than just a housekeeper. , 2009, Trends in cell biology.

[40]  M. Karin.  Nuclear factor-kappaB in cancer development and progression. , 2006, Nature.

[41]  P. Pinton,et al.  Bcl-2 and Ca2+ homeostasis in the endoplasmic reticulum , 2006, Cell Death and Differentiation.

[42]  Xiang Li,et al.  Targeting Bcl-2-IP3 receptor interaction to reverse Bcl-2's inhibition of apoptotic calcium signals. , 2008, Molecular cell.

[43]  Teruo Hayashi,et al.  Regulating ankyrin dynamics: Roles of sigma-1 receptors. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Teruo Hayashi,et al.  Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. , 2007, Cell.